Related Experiment Video
Updated: Feb 22, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Multiple Roles and Therapeutic Targets of Tuft Cells in Inflammatory Bowel Disease
1SKUMS: Shahrekord University of Medical Science, Shahrekord, Iran.
Abstract:
Tuft cells are rare epithelial chemosensory cells located in diverse organs, including the gut tract, and are characterized by large apical protrusions. Known as gut sentinels, tuft cells release widespread immunological effector molecules in response to gut luminal pathogens. Specifically, tuft cells are major regulators in initiating immune responses against certain nematodes and parasites. Another tuft cell property is the maintenance of gut hemostasis and modulation of the gut microbiome, which reduces intestinal inflammation. On the other hand, the pathophysiology of inflammatory bowel disease (IBD) is strongly linked to dysregulated immune responses, imbalances in the gut microbiome, and disruption of the mucosal barrier integrity. Hence, this review discusses tuft cell-mediated immune system response and its activation through luminal pathogens. It also addresses how the succinate-tuft cell axis plays a role in gut microbiome modulation. Finally, therapeutic options of tuft cell molecular effectors and their signaling pathways in IBD treatment are highlighted.
More Related Videos
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...